| 发明名称 | Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity | ||
| 摘要 | Injectable pharmaceutical compositions containing 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione dimaleate as active ingredient in the form of a lyophilized powder with a carrier selected from lactose and dextran, mixed with sodium chloride. | ||
| 申请公布号 | US9211262(B2) | 申请公布日期 | 2015.12.15 |
| 申请号 | US201012964861 | 申请日期 | 2010.12.10 |
| 申请人 | CTI BioPharma Corp. | 发明人 | Bernareggi Alberto;Livi Valeria |
| 分类号 | A61K9/19;A61K9/00;A61K47/02;A61K47/26;A61K47/36 | 主分类号 | A61K9/19 |
| 代理机构 | Seed IP Law Group PLLC | 代理人 | Seed IP Law Group PLLC |
| 主权项 | 1. A pharmaceutical composition, comprising 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione dimaleate and a lactose carrier mixed with sodium chloride, wherein the weight ratio between the carrier and sodium chloride is between 1:1 and 3:1, and wherein the composition is in lyophilized form. | ||
| 地址 | Seattle WA US | ||